EPIX Insider Trading Activity and SEC Form 4 Filings
EPIX insider trading summary
No open-market insider purchases or sales of ESSA Pharma Inc. (EPIX) have been reported on SEC Form 4 in the past 12 months.
Latest EPIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 5, 2025 | Bvf Inc/Il | 10% Owner | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Bvf I Gp LLC | 10% Owner | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Bvf II Gp LLC | Insider | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Bvf Gp Holdings LLC | 10% Owner | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | BVF Partners OS Ltd. | Insider | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Bvf Partners L P/Il | 10% Owner | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Biotechnology Value Fund II LP | Insider | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Biotechnology Value Fund L P | 10% Owner | Sell | $148 (79 @ $1.88) |
| Aug 5, 2025 | Bvf II Gp LLC | Insider | Sell | $124 (66 @ $1.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.